Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017613 |
---|---|
Receipt number | R000020414 |
Scientific Title | Japanese prospective observational study on the current state and efficacy of diagnosis and therapeutics for large vessel vasculitis, -Takayasu's arteritis and Giant cell arteritis- |
Date of disclosure of the study information | 2015/05/18 |
Last modified on | 2023/06/05 01:32:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/05/18 23:51:18 | ||
2 | Update | 2015/11/18 12:48:02 | Recruitment status |
|
3 | Update | 2015/11/18 12:56:08 | Institutions |
|
4 | Update | 2016/05/18 10:29:18 | Name of primary person or sponsor Organization Category of Funding Organization Research ethics review |
|
5 | Update | 2017/11/19 22:49:33 | Division name Division name |
|
6 | Update | 2017/11/19 22:51:33 | Institutions |
|
7 | Update | 2019/05/22 12:14:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/05/22 12:16:44 | Recruitment status Date of IRB |
|
9 | Update | 2019/05/22 12:18:11 | Number of participants that the trial has enrolled |
|
10 | Update | 2022/06/06 11:33:29 | Institutions |
|
11 | Update | 2022/06/06 11:35:57 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2022/11/29 03:11:00 | Date trial data considered complete Date analysis concluded |
|
13 | Update | 2023/06/05 01:32:23 | URL releasing protocol URL related to results and publications Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |